NASHVILLE, Tenn., June 9, 2021 /PRNewswire/ -- The U.S. Patent and Trademark Office has issued Concert Genetics patent US10,896,405B1 for innovative methods that enable real-time coverage determination and accurate reimbursement of genetic tests, the company announced today. As the patent...
Concert Genetics is a healthcare technology company that offers genetic test selection, ordering and payment management for hospitals and laboratories.